Exploiting new approaches for selective inhibition of trypsins

Project: Research project

Project Details


PROJECT NARRATIVE Trypsins are proteins that mediate disease processes in cancer and pancreatitis. More selective inhibitors are needed to target trypsins in order to study the roles of these proteins in diseases and as a stepping stone to developing better drugs to treat these diseases. In this project, we will develop highly selective trypsin inhibitors, along with innovative new methods for studying interactions between proteins that will be applicable to unraveling many disease processes and developing new drugs.
Effective start/end date1/1/2211/30/22


  • National Institute of General Medical Sciences: $301,404.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.